Intestinal bypass in morbid obesity: long-term metabolic sequelae.
A review of 51 patients undergoing jejunoileal bypass for morbid obesity is presented. There were two postoperative deaths; the 49 remaining patients have been followed for up to five years. Weight loss has been acceptable, the complications for the most part being transient and easily controlled. We believe that jejunoileal bypass for morbid obesity is a useful treatment modality in carefully selected patients.
D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D002338:Carotenoids / Q000097:blood; D003967:Diarrhea / Q000209:etiology; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000209:etiology; D006801:Humans; D007082:Ileum / Q000601:surgery*; D007583:Jejunum / Q000601:surgery*; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008099:Liver / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000378:metabolism / Q000628:therapy*; D011183:Postoperative Complications / Q000401:mortality; D013530:Surgical Wound Infection / Q000209:etiology*
D002338:Carotenoids; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase